Toggle navigation
Home
Search
Services
Blog
Contact
About
Tularemia Vaccine Development Team
Bolanowski, Mark
Search grants from Mark Bolanowski
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
University of Oklahoma Prevention Research Center
Grants for Geriatric Education Centers
Day Treatment Services for Ethnic Minorities in Hawaii
Non-Incarcerated Substance Abuse Treatment Program
Physics Teaching Resource Agent (PTRA)-PLUS
Recently added grants:
Critical Lipid Species in the Hepatovirus Lifecycle
Functions and mechanisms of transcriptional coactivator OCA-B in B cell development and lymphomagenesis
TGF beta - Regulated EMT
Cancer prevention and treatment by activation of a brain-adipocyte axis
The Role of Ribosomal Proteins in the P53-MDM2 Pathway
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI50041-5-0-0
Application #
7543574
Study Section
Project Start
2005-09-30
Project End
2010-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
$6,978,780
Indirect Cost
Related projects
NIH 2007
N01 AI
Tularemia Vaccine Development Team
Bolanowski, Mark /
$6,978,780
NIH 2007
N01 AI
Tularemia Vaccine Development Team
/
Comments
Be the first to comment on Mark Bolanowski's grant